Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 18, Number 11—November 2012

Research

Unchanged Severity of Influenza A(H1N1)pdm09 Infection in Children during First Postpandemic Season

Mathias AltmannComments to Author , Lena Fiebig, Silke Buda, Rüdiger von Kries, Manuel Dehnert, and Walter Haas
Author affiliations: Robert Koch Institute, Berlin, Germany (M. Altmann, L. Fiebig, S. Buda, M. Dehnert, W. Haas); and Ludwig-Maximilians-Universität, München, Germany (R. von Kries)

Main Article

Table 3

Comparison of severe cases of influenza A(H1N1)pdm09 infection among children in PICUs during the pandemic and first postpandemic influenza seasons, Germany, 2009–2011*

Variable No. patients/no. total (%) Nonsurvivors Survivors‡ Univariable analysis
Multivariable analysis
OR (95% CI) p value OR (95% CI) p value
Male sex 81/148 (55) 15/25 (60) 66/123 (54) 1.3 (0.5–3.5) 0.661 2.5 (0.8–7.4) 0.098
Median age, years (IQR) 4.2 (1.0–8-6) 5.7 (1.6–9.8) 4.1 (1–7.8) NA 0.091 1.1 (1.0–1.2) 0.232
2010–11 season 44/150 (29) 9/25 (36) 35/125 (28) 1.4 (0.5–3.9) 0.4728 1.6 (0.5–5.1) 0.435
Hospital-acquired infection 18/130 (14) 4/22 (18) 14/108 (13) 1.5 (0.3–5.5) 0.507 NA NA
Clinical diagnosis

Pneumonia

103/150 (69) 13/25 (52) 90/125 (72) 0.4 (0.2–1.1) 0.060 NA NA

Secondary pneumonia

30/150 (20) 8/25 (32) 22/125 (18) 2.2 (0.7–6.2) 0.108 NA NA

Encephalopathy

11/150 (7) 1/25 (4) 10/125 (8) 0.5 (0.01–3.7) 0.692 NA NA

ARDS

43/150 (29) 15/25 (60) 28/125 (22) 5.2 (1.9–14.3) <0.001 3.2 (1.1–9.2) 0.029

Sepsis

17/150 (11) 6/25 (24) 11/125 (9) 3.3 (0.9–11.0) 0.040 NA NA

Myocarditis

8/150 (5) 4/25 (16) 4/125 (3) 5.8 (1.0–32.9) 0.027 30.9 (2.6–360.7) 0.006

Febrile seizure

7/150 (5) 0/25 (0) 7/125 (6) 0.0 (0.01–2.7) 0.601 NA NA
Underlying chronic medical condition

Any

108/140 (77) 19/23 (83) 89/117 (76) 1.5 (0.4–6.5) 0.596 NA NA

Neurodevelopmental disorder

78/145 (54) 16/24 (67) 62/121 (51) 1.9 (0.7–5.5) 0.186 NA NA

Respiratory disease

42/135 (31) 8/22 (36) 34/113 (30) 1.3 (0.4–3.8) 0.617 NA NA

Immunodeficiency

16/131 (12) 1/21 (5) 15/110 (14) 0.3 (0.0–2.3) 0.467 NA NA

Cardiac disease

20/137 (15) 4/23 (17) 16/114 (14) 1.3 (0.3–4.6) 0.746 NA NA
Treatment

Oseltamivir

87/139 (63) 15/23 (65) 72/116 (62) 1.1 (0.4–3.4) 0.8185 NA NA

Catecholamine

52/133 (39) 16/23 (70) 36/110 (33) 4.7 (1.6–14.6) 0.002 NA NA

Mechanical ventilation

98/140 (70) 23/24 (96) 75/116 (65) 12.6 (1.9–530.3) 0.001 18.3 (1.3–251.6) 0.030

Vaccination†

5/82 (6) 0/14 (0) 5/68 (7) 0.0 (0.0–3.7) 0.582 NA NA

*Values are no. positive/no. with available information (%), except as indicated. PICUs, pediatric intensive care units; pandemic season, 2009–10; postpandemic season, 2010–11; OR, odds ratio; IQR, interquartile range; NA, not applicable; ARDS, acute respiratory distress syndrome.
†Influenza A(H1N1)pdm09 vaccination of patients >6 mo of age.

Main Article

TOP